DIXIE GROUP INC (DXYN)
US2555191004 - Common Stock
We assign a fundamental rating of 2 out of 10 to DXYN. DXYN was compared to 67 industry peers in the Household Durables industry. Both the profitability and financial health of DXYN have multiple concerns. DXYN has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year DXYN has reported negative net income.
DXYN had a positive operating cash flow in the past year.
In multiple years DXYN reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: DXYN reported negative operating cash flow in multiple years.
1.2 Ratios
DXYN has a Return On Assets of -1.43%. This is in the lower half of the industry: DXYN underperforms 71.21% of its industry peers.
Looking at the Return On Equity, with a value of -9.35%, DXYN is doing worse than 75.76% of the companies in the same industry.
DXYN has a Return On Invested Capital of 0.09%. This is in the lower half of the industry: DXYN underperforms 71.21% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.43% | ||
| ROE | -9.35% | ||
| ROIC | 0.09% |
ROA(3y)-6.01%
ROA(5y)-3.16%
ROE(3y)-39.43%
ROE(5y)-22.36%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Operating Margin, with a value of 0.06%, DXYN is doing worse than 72.73% of the companies in the same industry.
DXYN's Gross Margin of 26.71% is in line compared to the rest of the industry. DXYN outperforms 53.03% of its industry peers.
In the last couple of years the Gross Margin of DXYN has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.06% | ||
| PM (TTM) | N/A | ||
| GM | 26.71% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.39%
GM growth 5Y4.47%
2. Health
2.1 Basic Checks
DXYN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
DXYN has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, DXYN has less shares outstanding
The debt/assets ratio for DXYN has been reduced compared to a year ago.
2.2 Solvency
DXYN has an Altman-Z score of 0.64. This is a bad value and indicates that DXYN is not financially healthy and even has some risk of bankruptcy.
DXYN's Altman-Z score of 0.64 is on the low side compared to the rest of the industry. DXYN is outperformed by 84.85% of its industry peers.
The Debt to FCF ratio of DXYN is 50.62, which is on the high side as it means it would take DXYN, 50.62 years of fcf income to pay off all of its debts.
DXYN has a Debt to FCF ratio of 50.62. This is in the lower half of the industry: DXYN underperforms 72.73% of its industry peers.
DXYN has a Debt/Equity ratio of 2.69. This is a high value indicating a heavy dependency on external financing.
DXYN's Debt to Equity ratio of 2.69 is on the low side compared to the rest of the industry. DXYN is outperformed by 92.42% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.69 | ||
| Debt/FCF | 50.62 | ||
| Altman-Z | 0.64 |
ROIC/WACC0.01
WACC6.88%
2.3 Liquidity
DXYN has a Current Ratio of 2.84. This indicates that DXYN is financially healthy and has no problem in meeting its short term obligations.
With a Current ratio value of 2.84, DXYN perfoms like the industry average, outperforming 53.03% of the companies in the same industry.
DXYN has a Quick Ratio of 2.84. This is a bad value and indicates that DXYN is not financially healthy enough and could expect problems in meeting its short term obligations.
DXYN's Quick ratio of 0.91 is on the low side compared to the rest of the industry. DXYN is outperformed by 60.61% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.84 | ||
| Quick Ratio | 0.91 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 96.44% over the past year.
The Revenue has decreased by -8.97% in the past year.
Measured over the past years, DXYN shows a decrease in Revenue. The Revenue has been decreasing by -7.36% on average per year.
EPS 1Y (TTM)96.44%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q118.49%
Revenue 1Y (TTM)-8.97%
Revenue growth 3Y3.27%
Revenue growth 5Y-7.36%
Revenue growth Q2Q-5.43%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for DXYN. In the last year negative earnings were reported.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
DXYN's Enterprise Value to EBITDA ratio is in line with the industry average.
Based on the Price/Free Cash Flow ratio, DXYN is valued cheaper than 84.85% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 5.1 | ||
| EV/EBITDA | 12.09 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
DXYN does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
DIXIE GROUP INC
NASDAQ:DXYN (4/30/2024, 7:00:02 PM)
Premarket: 0.5378 0 (-0.11%)0.5384
+0 (+0.71%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap8.36M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.43% | ||
| ROE | -9.35% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 0.06% | ||
| PM (TTM) | N/A | ||
| GM | 26.71% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.45
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.69 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 2.84 | ||
| Quick Ratio | 0.91 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)96.44%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-8.97%
Revenue growth 3Y3.27%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y